Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $41.3700 (-0.53%) ($41.3700 - $41.3700) on Mon. Oct. 10, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.07% (three month average) | RSI | 56 | Latest Price | $41.3700(-0.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.7% a day on average for past five trading days. | Weekly Trend | HALO advances 3.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(40%) IFRA(33%) IWM(33%) IWO(33%) IWN(32%) | Factors Impacting HALO price | HALO will decline at least -1.035% in a week (0% probabilities). VIXM(-10%) VXX(-6%) UUP(-3%) TBT(-3%) USO(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.035% (StdDev 2.07%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $41.59(-0.53%) | 10 Day Moving Average | $40.64(1.8%) | 20 Day Moving Average | $40.54(2.05%) | To recent high | -20.2% | To recent low | 7.4% | Market Cap | $5.654b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |